News from Berg A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 13, 2017, 09:00 ET New Research Partnership will Leverage BERG Interrogative Biology® Platform and Identify Novel Biomarker and Targets for Diagnosis and Treatment of Alzheimer's Disease

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, Massachusetts General Hospital (MGH), and...


Oct 30, 2017, 09:00 ET BERG Enters Into an Agreement With Sanofi Pasteur to Identify Biomarkers of Flu Vaccine Performance

BERG, a biopharmaceutical company that merges biology with technology, today announced a new research effort with Sanofi Pasteur, the influenza...


Oct 27, 2017, 09:00 ET BERG Honored with Partner in Progress Award from DEBRA of America at Annual Benefit for Rare Disease Epidermolysis Bullosa (EB)

BERG, a biopharmaceutical company that merges biology with technology, today announced that the Company was honored with a Partners in Progress...


Sep 19, 2017, 08:00 ET BERG Broadens Relationship With The Department Of Defense (DoD) Center For Prostate Disease Research With New Predictive Biomarker Test For Prostate Cancer

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the completion of clinical...


Sep 11, 2017, 09:00 ET BERG Presents Key Clinical Data at ESMO 2017 on BPM 31510 for Advanced Pancreatic Cancer Patients and BPM 31543 for Preventing Hair-Loss in Patients Treated With Chemotherapy

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced two poster presentations...


Aug 28, 2017, 12:00 ET BERG Forms Research Collaboration with AstraZeneca to Identify New Therapeutic Targets to Treat Neurological Disorders such as Parkinson's Disease

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced a research collaboration with...


May 15, 2017, 09:00 ET BERG Announces New Partnership with debra of America to Tackle Epidermolysis Bullosa-a Rare Genetic Tissue Disorder

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced they have...


Apr 03, 2017, 09:00 ET BERG Announces BPM 31510 Data Presentations at 2017 AACR in Immuno-Oncology, Glioblastoma Mutiforme, Pancreatic Cancers and Novel Prostate Cancer Biomarker Panel

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced seven poster...


Mar 27, 2017, 11:35 ET New Data Published in Nature Medicine from Joslin Diabetes Center Demonstrates the Importance of Interrogating Human Biology

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that the...


Feb 15, 2017, 09:04 ET BERG Initiates Phase I/II Monotherapy Trial of BPM 31510-IV in Patients with Glioblastoma Multiforme (GBM)

BERG LLC, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that it has...


Feb 07, 2017, 09:02 ET BERG Announces Appointment of Titus Plattel as Chief Operating Officer

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced the appointment...


Jan 12, 2017, 13:00 ET BERG Enters into Multi-Year Agreement with BD for Next-Generation Analytics in Healthcare IT

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, announced a multi-year agreement...


Nov 14, 2016, 13:13 ET BERG Presents Data Uncovering a Novel Contributor to Parkinson's Disease at Society for Neuroscience 2016 Meeting

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today unveiled data from a...


Oct 31, 2016, 08:57 ET BERG, The Icahn School of Medicine at Mount Sinai to host "Fast Track" event at Fast Company's Second Annual Innovation Festival 2016

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, and the Icahn School of Medicine...


Oct 24, 2016, 09:04 ET BERG Expands Research Collaboration with Department of Defense and Walter Reed National Military Medical Center to Advance Precision Medicine for Breast Cancer Patients

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that it has...


Aug 17, 2016, 14:17 ET BERG Strengthens Financial Leadership And Expands Board Of Directors

 BERG, a technology-based biopharmaceutical company uncovering health solutions through a data-driven, systems biological research approach,...


Jul 28, 2016, 17:38 ET BERG Promotes Coveney To Vice President Of Finance And Controller

 BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced the...


Jun 05, 2016, 11:06 ET BERG Announces Clinical Trial Data Presentations Of BPM 31510 In Advanced Solid Tumors And BPM 31543 For Prevention Of Chemotherapy-Induced Alopecia At American Society of Clinical Oncology Annual Meeting

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that it will...


Apr 27, 2016, 10:00 ET BERG Initiates Phase II Combination Trial Of BPM 31510 And Gemcitabine In Patients With Pancreatic Cancer

 BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that it has...


Feb 23, 2016, 09:04 ET BERG Appoints Michael A. Kiebish As Chief Precision Medicine Officer

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced the appointment...


Feb 09, 2016, 09:02 ET BERG Appoints Narain To Chief Executive Officer; Haddock Joins As Chief Financial Officer/ Chief Operating Officer

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, has announced the...


Sep 30, 2015, 10:23 ET Berg Joins U.K. Prime Minister's Initiative, Genomics England to Sequence 100,000 Genomes

 Berg, a Boston-based biopharmaceutical company at the forefront of precision medicine, today announced it will join an industry...


Sep 08, 2015, 08:46 ET National Institutes of Health to Evaluate Berg's Drug for the Treatment of Kidney Cancer

 Berg, a Boston-based biopharmaceutical company, has announced that it has entered into a Materials-Cooperative Research and Development...


Apr 07, 2015, 19:27 ET Lancement de Project Survival(SM) : une collaboration qui vise à dévoiler le tout premier biomarqueur du cancer du pancréas

-- Berg, le Centre de cancérologie du BIDMC, et l'Équipe de recherche sur le cancer du pancréas du CRAB travaillent ensemble afin...


Apr 07, 2015, 16:11 ET Start von Project Survival(SM): Kooperation zielt darauf ab, den allerersten Biomarker für Bauchspeicheldrüsenkrebs zu entdecken

-- Berg, BIDMC Cancer Center und CRAB/Pancreatic Cancer Research Team arbeiten zusammen, um die Erkrankung auszumerzen  Forschungen zur...